Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

United Community Banks Exceeds Earnings Expectations but Falls Short on Sales

Elaine Mendonca by Elaine Mendonca
January 24, 2024
in Breaking News
0
Banking Trading online
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On January 24, 2024, United Community Banks (NASDAQ: UCBI) announced their quarterly earnings, exceeding expectations with earnings of $0.53 per share, surpassing the analyst consensus estimate of $0.52 by 1.92 percent. This indicates a decline of 29.33 percent compared to the earnings of $0.75 per share reported in the corresponding period last year.

Furthermore, the company disclosed their quarterly sales of $180.36 million, falling short of the analyst consensus estimate of $226.07 million by 20.22 percent. This represents a decrease of 25.85 percent in comparison to the sales of $243.24 million during the same period last year.

For further details and comprehensive information, kindly visit the official investor relations website of the company or refer to trusted financial news sources.

United Community Banks, Inc. (UCBI) Stock Price Shows Stability and Potential for Long-Term Growth

On January 24, 2024, United Community Banks, Inc. (UCBI) experienced a slight drop in its stock price. The stock closed at $29.10, marking a decrease of $0.59 or 1.99% since the previous market close. UCBI remains in a relatively stable position in terms of its price momentum.

UCBI is trading in the middle of its 52-week range, indicating stability and suggesting that its stock price has not been subject to extreme fluctuations.

UCBI is trading above its 200-day simple moving average, which suggests that the stock’s price is generally on an upward trajectory over the long term. This is a positive signal for UCBI.

The decline of 1.99% on January 24 is relatively small and may not be indicative of a significant trend. After-hours trading showed no change in the stock price, suggesting that investors are not reacting strongly to the drop.

Overall, UCBI remains in a stable position. Investors should continue to monitor the stock’s performance for any potential trends or changes.

UCBI Stock Performance on January 24, 2024: Positive and Negative Indicators

UCBI Stock Performance on January 24, 2024:

Total revenue: $941.67 million over the past year, representing a 27.44% increase compared to the previous year.

Total revenue from the third quarter: $354.15 million, a 6.76% increase compared to the previous quarter.

Net income: $276.01 million over the past year, remaining flat compared to the previous year.

Net income from the third quarter: $47.61 million, a 24.37% decrease compared to the previous quarter.

Earnings per share (EPS): $2.52 over the past year, a 15.01% decrease compared to the previous year.

EPS from the third quarter: $0.39, a 26.0% decrease compared to the previous quarter.

In conclusion, UCBI’s stock performance on January 24, 2024, exhibited a mix of positive and negative indicators. While their total revenue increased by 27.44% over the past year, the rate of growth slowed down compared to the previous year. The net income remained flat since last year, and a significant decline was observed in the most recent quarter. The earnings per share also experienced declines both on a yearly and quarterly basis. Investors should closely monitor these financial metrics to gain a comprehensive understanding of UCBI’s financial health and make informed decisions regarding their investment in UCBI stock.

Tags: UCBI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Stock Charts (2)

Analyst Upgrades StoneCo Stock to Neutral with 23 Price Target

Finance_ projections

SciSparc Ltd Secures 20 Million Standby Equity Purchase Agreement with YA II PN Ltd for Accelerated Growth and Expansion

Johnson Johnson Reports Strong Financial Results and Addresses Concerns

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com